BSE filing, NSE: GANGAPA. Summary written from the filing by ALFA Finder's alert engine.
Ganga Papers India Ltd: key numbers
- Share price
- ₹86.00
- Market cap
- ₹92.78 Cr
- Revenue (annual)
- ₹280.2 Cr
- Net profit (annual)
- ₹1.60 Cr
- P/E (TTM)
- 51.8×Sector 36.4×
- Promoter holding
- 74.98%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ganga Papers India Ltd
All →Ganga Papers India Management Change
Ganga Papers India Ltd shareholders approved the continuation of Ramesh Kumar Chaudhary as Non-Executive Director beyond age 75. The decision was ratified during the 42nd AGM.
Ganga Papers India Annual General Meeting
Ganga Papers India Limited held its 42nd Annual General Meeting on September 28, 2026. Shareholders considered five resolutions including adoption of financial statements and reappointment of directors.
Ganga Papers India Annual General Meeting
Ganga Papers India Ltd scheduled its 42nd Annual General Meeting for September 28, 2026, to transact business including financial adoption and director appointments.
Ganga Papers India Other Announcement
Ganga Papers India Ltd. has appointed M/s. K.N. Chaubey & Associates as the Cost Auditor of the company for the financial year 2026-27.
Ganga Papers India Management Change
Ganga Papers India Ltd announced the resignation of director Manish Kumar and appointed Ramesh Kumar Chaudhary as the new Chairperson, effective August 31, 2026.
Ganga Papers India Board Meeting Outcome
Ganga Papers India Ltd.'s board meeting outcome includes director resignations, appointment of a new chairperson, and approval of the upcoming AGM agenda. These changes mark leadership updates.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.